Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Phillips, PPJ"'
Autor:
Dierig, A, Hoelscher, M, Schultz, S, Hoffmann, L, Jarchow-MacDonald, A, Svensson, EM, Te Brake, L, Aarnoutse, R, Boeree, M, McHugh, TD, Wildner, LM, Gong, X, Phillips, PPJ, Minja, LT, Ntinginya, N, Mpagama, S, Liyoyo, A, Wallis, RS, Sebe, M, Mhimbira, FA
Publikováno v:
Trials; 6/6/2023, Vol. 24 Issue 1, p1-15, 15p, 1 Diagram, 2 Charts
Autor:
Stagg, HR, Bothamley, GH, Davidson, JA, Kunst, H, Lalor, MK, Lipman, MC, Loutet, MG, Lozewicz, S, Mohiyuddin, T, Abbara, A, Alexander, E, Booth, H, Creer, DD, Harris, RJ, Kon, OM, Loebinger, MR, McHugh, TD, Milburn, HJ, Palchaudhuri, P, Phillips, PPJ, Schmok, E, Taylor, L, Abubakar, I, on behalf of the London INH-R TB study group
Publikováno v:
Stagg, HR, Bothamley, GH, Davidson, JA, Kunst, H, Lalor, MK, Lipman, MC, Loutet, MG, Lozewicz, S, Mohiyuddin, T, Abbara, A, Alexander, E, Booth, H, Creer, DD, Harris, RJ, Kon, OM, Loebinger, MR, McHugh, TD, Milburn, HJ, Palchaudhuri, P, Phillips, PPJ, Schmok, E, Taylor, L, Abubakar, I & on behalf of the London INH-R TB study group 2019, ' Fluoroquinolones and isoniazid resistant TB: implications for the 2018 WHO guidance ', European Respiratory Journal . https://doi.org/10.1183/13993003.00982-2019
INTRODUCTION: 2018 World Health Organization (WHO) guidelines for the treatment of isoniazid (H) resistant (Hr) tuberculosis recommend a four-drug regimen- rifampicin (R), ethambutol (E), pyrazinamide (Z) and levofloxacin (Lfx)- with or without H ([H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3094::864289ea171abbab727618a98212080e
https://hdl.handle.net/20.500.11820/3a174724-f9c1-40d6-88b7-f33a892c9b93
https://hdl.handle.net/20.500.11820/3a174724-f9c1-40d6-88b7-f33a892c9b93
Autor:
Murthy, SE, Chatterjee, F, Crook, A, Dawson, R, Mendel, C, Murphy, ME, Murray, SR, Nunn, AJ, Phillips, PPJ, Singh, KP, McHugh, TD, Gillespie, SH, Consortium, REMoxTB
Publikováno v:
BMC Medicine, Vol 16, Iss 1, Pp 1-11 (2018)
BMC medicine, vol 16, iss 1
BMC medicine, vol 16, iss 1
Background: Chest radiographs are used for diagnosis and severity assessment in tuberculosis (TB). The extent of disease as determined by smear grade and cavitation as a binary measure can predict 2-month smear results, but little has been done to de
Publikováno v:
Clinical trials (London, England), vol 15, iss 5
Background Trials to identify the minimal effective treatment duration are needed in different therapeutic areas, including bacterial infections, tuberculosis and hepatitis C. However, standard non-inferiority designs have several limitations, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::42e4466daa6cdf33e288dc3b730ab867
https://doi.org/10.1177/1740774518778027
https://doi.org/10.1177/1740774518778027
Autor:
Aarnoutse, RE, Kibiki, GS, Reither, K, Semvua, HH, Haraka, F, Mtabho, CM, Mpagama, SG, van den Boogaard, J, Sumari-de Boer, IM, Magis-Escurra, C, Wattenberg, M, Logger, JGM, Te Brake, LHM, Hoelscher, M, Gillespie, SH, Colbers, A, Phillips, PPJ, Plemper van Balen, G, Boeree, MJ, PanACEA Consortium
Publikováno v:
Antimicrobial agents and chemotherapy, vol 61, iss 11
In a multiple-dose-ranging trial, we previously evaluated higher doses of rifampin in patients for 2 weeks. The objectives of the current study were to administer higher doses of rifampin for a longer period to compare the pharmacokinetics, safety/to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::043f76518f850ff5ff1b1fe1ccf9a781
https://escholarship.org/uc/item/08z4903k
https://escholarship.org/uc/item/08z4903k
Autor:
Nahid, Payam, Phillips, PPJ, Dooley, KE, Gillespie, SH, Heinrich, N, Stout, JE, Diacon, AH, Aarnoutse, RE, Kibiki, GS, Boeree, MJ
Publikováno v:
Nahid, Payam; Phillips, PPJ; Dooley, KE; Gillespie, SH; Heinrich, N; Stout, JE; et al.(2016). A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP). UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/8cv271t5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______325::0aa2b68d6582a0665731a17cc7854072
http://www.escholarship.org/uc/item/8cv271t5
http://www.escholarship.org/uc/item/8cv271t5
Autor:
Aggarwal I; University of Illinois College of Medicine, Chicago, IL, USA.; Center for Global Health, University of Illinois at Chicago, Chicago, IL, USA., Chaisson LH; Center for Global Health, University of Illinois at Chicago, Chicago, IL, USA.; Division of Infectious Diseases, Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Opira B; Infectious Diseases Research Collaboration, Kampala, Uganda., Dowdy DW; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Phillips PPJ; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA., Semitala FC; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.; Makerere University Joint AIDS Program, Kampala Uganda., Yoon C; Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
Publikováno v:
IJTLD open [IJTLD Open] 2024 Jul 01; Vol. 1 (7), pp. 323-325. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).
Autor:
Metcalfe JZ; Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco., Economou T; Department of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa., Naufal F; Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco., Kucukosmanoglu M; D-Prime LLC, McLean, Virginia., Kleiman R; Clario Inc, Philadelphia, Pennsylvania., Phillips PPJ; Division of Pulmonary and Critical Care Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco., Conradie F; Department of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Jun 03; Vol. 7 (6), pp. e2415576. Date of Electronic Publication: 2024 Jun 03.
Autor:
Dufault SM; Division of Biostatistics, University of California, San Francisco, San Francisco, California, USA.; UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco, California, USA., Davies GR; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK., Svensson EM; Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden., Sloan DJ; School of Medicine, University of St Andrews, St Andrews, United Kingdom., McCallum AD; Department of Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Patel A; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA., Van Brantegem P; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, USA., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, South Africa., Phillips PPJ; UCSF Center for Tuberculosis, University of California, San Francisco, San Francisco, California, USA.; Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, California, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 May 07. Date of Electronic Publication: 2024 May 07.
Autor:
Derendinger B; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Mochizuki TK; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, USA., Marcelo D; De La Salle Medical Health Sciences Institute, Dasmariñas City, Philippines., Shankar D; Department of Pulmonary Medicine, Christian Medical College, Vellore, India., Mangeni W; Walimu and Makerere University College of Health Sciences, Kampala, Uganda., Nguyen H; National Lung Hospital, Hanoi, Vietnam., Yerikaya S; Department of Infectious Disease and Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital; German Center for Infection Research, partner site, Heidelberg, Germany., Worodria W; Walimu and Makerere University College of Health Sciences, Kampala, Uganda., Yu C; De La Salle Medical Health Sciences Institute, Dasmariñas City, Philippines., Nguyen NV; National Lung Hospital, Hanoi, Vietnam., Christopher DJ; Department of Pulmonary Medicine, Christian Medical College, Vellore, India., Theron G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Phillips PPJ; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, USA., Nahid P; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, USA., Denkinger CM; Department of Infectious Disease and Tropical Medicine, Center for Infectious Diseases, Heidelberg University Hospital; German Center for Infection Research, partner site, Heidelberg, Germany., Cattamanchi A; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, USA.; Division of Pulmonary Diseases and Critical Care Medicine, University of California Irvine, Irvine, CA., Yoon C; Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, USA.; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Apr 24. Date of Electronic Publication: 2024 Apr 24.